Rheumatoid Arthritis Completed Phase Trials for Rituximab (DB00073)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03496831Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs
NCT01613027An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis
NCT01592292An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy
NCT01641952An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent
NCT02699892Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis
NCT02622503A Study on Rheumatoid Arthritis Patients Treated With Rituximab
NCT00844714Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab TherapyTreatment
NCT00854321Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital
NCT00963703Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid ArthritisTreatment
NCT01075477An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)
NCT01071798An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis